Astragalus Injection was used to treat 40 cases of viral hepatitis patients, among which 30 cases were jaundice hepatitis, accounting for 75%, and 10 cases were non-jaundice hepatitis, accounting for 25%. The main symptoms included malaise, abdominal distension, fever, yellow eyes, nausea, vomiting, abdominal distension, liver pain, malaise, anorexia, etc.
1.3 Liver function tests: ① T-Bil8.1 ~ 65.9p. mol / L; ② D-Bil4.1-43.8p. mol / L; (To) the Ar207 801U / L; ~ ~ r2o, ~ 180U.
1.4 Treatment: According to the condition, proper rest and nutrition were given to prevent fatigue and mental stimulation, avoid drinking and drug use detrimental to the liver. At the same time, a daily intravenous drip of 250ml of 5% glucose + 20 ~ 30ml Astragalus Injection was administered once a day for 20 days as a course of treatment for liver care.
1.5 Monitoring items: Clinical symptoms and signs, laboratory tests.
2 Results
2.1 Efficacy criteria: After one course of treatment, clinical symptoms disappeared and liver function returned to normal as cured; clinical symptoms reduced and liver function significantly improved as markedly effective; without any improvement in clinical symptoms and liver function as ineffective.
2.2 Results: Among the 40 cases, with proper rest, proper nutrition, liver treatment, and intravenous treatment of 250ml of 5% glucose + 20 ~ 30ml Astragalus Injection as a course of treatment, 34 cases were cured, accounting for 85%; six cases were effective, accounting for 15%; and no cases were ineffective. During the application of Astragalus Injection, no adverse reactions were confirmed.
3 Discussion
Viral hepatitis is an infectious disease caused by various hepatitis viruses leading to liver damage. It includes hepatitis A, B, C, D, E, etc. Acute cases usually recover within 2 to 4 months after onset. Hepatitis B, C, and D can become chronic or develop into liver cirrhosis and hepatocellular carcinoma. Hepatitis A and E generally do not develop into chronic conditions or cirrhosis. This article focuses on hepatitis A.
Hepatitis A spreads through fecal-water pollution and aquatic shellfish dyeing, causing outbreaks via daily contact, blood transfusion, and injection. Its incidence is closely related to pre-school children, economic, and health levels. As an infectious disease, it causes great harm and requires prevention and control combined. Prevention must start from rural areas and children, popularizing hepatitis prevention knowledge, environmental sanitation, and personal hygiene. Water management and manure management should be strengthened, good food hygiene maintained, and disinfection systems implemented in nurseries and restaurants.
Once the disease occurs, early isolation is necessary, quarantined for three weeks from the date of onset, along with early treatment. Treatment emphasizes early bed rest, gradually increasing activity after significant symptom improvement, continuing rest for 3 months after clinical symptoms and liver function return to normal. Patients should be given a light diet to ensure adequate intake of calories and vitamins (especially B and C), appropriate protein intake, and use drugs that are effective and economical.
Our results show that Astragalus Injection is an economical and effective drug for treating hepatitis A. It not only shortens the disease duration but also reduces the economic burden and has no adverse reactions.